...па сигурно и ти гуглираш, не си присутен на лице место во лабораторија на BioNTech, ако веќе сакаш попрецизно моментален ,,изум,, на турски пар преселен во Германија Ugur Sahin и Ozlem Tureci кои претходно работеле во Ganymed Pharmaceuticals во 2001, меѓу најбогати 100 души во Германија, дури и медениот месец и прва брачна ноќ ја поминале во онколошката лабораторија,
,,...Sahin was born in Iskenderun, a city on Turkey's Mediterranean coast, moved to Cologne, Germany when he was four, where his father worked at a local Ford factory. He met Tureci, the daughter of a Turkish physician, when the pair were both embarking on their academic careers.
Прегледај го приврзокот 306122 Прегледај го приврзокот 306126
,,...Their Covid-19 vaccine approach uses genetic material, mRNA, to trick cells into producing bits of protein that look like pieces of the virus. The immune system learns to recognize and attack those bits and, in theory, would react fast to any actual infection.
It uses the never-before-approved technology called messenger RNA, or mRNA, to spark an immune response in people who are vaccinated.
Прегледај го приврзокот 306128 Прегледај го приврзокот 306129
Sahin, 55, and Tureci, 53, set up BioNTech in the central German city of Mainz in 2008. On Monday the company's partner, US pharmaceutical giant Pfizer, said their candidate vaccine was more than 90% effective in preventing infection in volunteers.
The pair, both trained physicians, established their previous company, Ganymed Pharmaceuticals, in 2001 to work on developing cancer-fighting antibodies, eventually selling it for $1.4 billion in 2016.
Chief Executive Sahin and Chief Medical Officer Tureci are listed among Germany's 100 richest people, according to the weekly Welt am Sonntag newspaper. On Tuesday, the market value of their Nasdaq-listed company jumped to $25.72 billion -- a massive leap from $4.6 billion last year....,,
www.theguardian.com
www.facebook.com
clinicaltrials.gov
